Last reviewed · How we verify
NCT03264040: BioMannosido
Biomarker for Mannosidosis Disease (BioMannosidosis)
trial in Alpha-Mannosidase B Deficiency. Withdrawn.
28 February 2021
Quick facts
| Lead sponsor | CENTOGENE GmbH Rostock |
|---|---|
| Status | Withdrawn |
| Study type | OBSERVATIONAL |
| Start date | 20 August 2018 |
| Primary completion | 28 February 2021 |
| Estimated completion | 28 February 2021 |
| Sites | 3 locations across Sri Lanka, Germany, India |
Conditions studied
- Alpha-Mannosidase B Deficiency — all drugs for Alpha-Mannosidase B Deficiency →
- Lysosomal Alpha B Mannosidosis — all drugs for Lysosomal Alpha B Mannosidosis →
- Alpha-Mannosidase Deficiency — all drugs for Alpha-Mannosidase Deficiency →
Sponsor
CENTOGENE GmbH Rostock
Who can join
2 Months and older, any sex, with Alpha-Mannosidase B Deficiency or Lysosomal Alpha B Mannosidosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Development of a new MS-based biomarker for the early and sensitive diagnosis of Mannosidosis disease from blood (plasma)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03264040
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other CENTOGENE GmbH Rostock trials
Trials by the same sponsor.
- NCT06040008 — Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals · completed
- NCT05075187 — Epidemiological Study in FRONtoTemporal Dementia · completed
- NCT04925804 — Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) · completed
- NCT04548921 — Biomarker for Friedreich's Ataxia (BioFridA) · unknown
- NCT03866590 — Pyruvate Kinase Deficiency Epidemiological Study (PIECE) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03264040 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CENTOGENE GmbH Rostock
- Last refreshed: 13 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03264040.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing